HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taylor Leaving FDA With Prevention As Food Safety Fundamental Strategy

This article was originally published in The Tan Sheet

Executive Summary

Michael Taylor retires as deputy commissioner for foods and veterinary medicine on June 1 and will be succeeded by Stephen Ostroff, until recently FDA's acting commissioner and previously CFSAN's chief medical officer and senior public health advisor to Taylor.

You may also be interested in...



FDA's Califf Seeks His First Big Hire: Chief Scientist

The US agency seeks candidates for the executive position in charge of its research policy apparatus.

FDA Chief Scientist Post A Chance For Califf To Make Mark

Agency seeks candidates for the executive position in charge of its research policy apparatus.

Prominent FDAer In Cosmetic Modernization Talks On Way Out

Michael Taylor retires as deputy commissioner for foods and veterinary medicine on June 1, leaving behind a legacy of regulatory work under the Food Safety Modernization Act of 2010. Taylor also was a key figure in the agency's past negotiations with industry on a legislative plan to modernize cosmetics oversight, and his departure could be felt by FDA and other stakeholders if current legislation of that nature passes.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel